APA (7th ed.) Citation

Amarenco, P., Goldstein, L. B., Sillesen, H., Benavente, O., Zweifler, R. M., Callahan, A., . . . Welch, K. M. A. (2010). Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: Findings from the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke, 41(3), . https://doi.org/10.1161/STROKEAHA.109.564781

Chicago Style (17th ed.) Citation

Amarenco, Pierre, Larry B. Goldstein, Henrik Sillesen, Oscar Benavente, Richard M. Zweifler, Alfred Callahan, Michael G. Hennerici, Justin A. Zivin, and K. Michael A. Welch. "Coronary Heart Disease Risk in Patients with Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial." Stroke 41, no. 3 (2010). https://doi.org/10.1161/STROKEAHA.109.564781.

MLA (9th ed.) Citation

Amarenco, Pierre, et al. "Coronary Heart Disease Risk in Patients with Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial." Stroke, vol. 41, no. 3, 2010, https://doi.org/10.1161/STROKEAHA.109.564781.